These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27819329)

  • 1. mTOR Overactivation in Mesenchymal cells Aggravates CCl
    Shan L; Ding Y; Fu Y; Zhou L; Dong X; Chen S; Wu H; Nai W; Zheng H; Xu W; Bai X; Jia C; Dai M
    Sci Rep; 2016 Nov; 6():36037. PubMed ID: 27819329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways.
    Shan C; Wang R; Wang S; Zhang Z; Xing C; Feng W; Zhao Z; Zhou S; Zhao AZ; Mu Y; Li F
    Exp Physiol; 2021 Apr; 106(4):983-993. PubMed ID: 33605486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
    Li Y; Lua I; French SW; Asahina K
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.
    Ma A; Wang L; Gao Y; Chang Z; Peng H; Zeng N; Gui YS; Tian X; Li X; Cai B; Zhang H; Xu KF
    Hum Mol Genet; 2014 Feb; 23(3):693-705. PubMed ID: 24129405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis.
    Hu B; Wu Z; Bai D; Liu T; Ullenbruch MR; Phan SH
    Am J Pathol; 2015 Nov; 185(11):3066-75. PubMed ID: 26358219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance.
    Gu L; Deng WS; Sun XF; Zhou H; Xu Q
    Mol Med Rep; 2016 Aug; 14(2):1153-61. PubMed ID: 27315465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis.
    Chatani N; Kamada Y; Kizu T; Ogura S; Furuta K; Egawa M; Hamano M; Ezaki H; Kiso S; Shimono A; Ouchi N; Yoshida Y; Takehara T
    Liver Int; 2015 Aug; 35(8):2017-26. PubMed ID: 25488180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
    Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
    Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
    Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
    Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
    Ding L; Han L; Li Y; Zhao J; He P; Zhang W
    Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
    Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
    J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice.
    Ogiso H; Ito H; Ando T; Arioka Y; Kanbe A; Ando K; Ishikawa T; Saito K; Hara A; Moriwaki H; Shimizu M; Seishima M
    PLoS One; 2016; 11(9):e0162183. PubMed ID: 27598994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.
    Hong F; Si C; Gao P; Cederbaum AI; Xiong H; Lu Y
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):33-43. PubMed ID: 26363552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
    Rensing N; Han L; Wong M
    Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
    Shrestha N; Chand L; Han MK; Lee SO; Kim CY; Jeong YJ
    Food Chem Toxicol; 2016 Jul; 93():129-37. PubMed ID: 27137983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
    Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
    J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways.
    Ji L; Xue R; Tang W; Wu W; Hu T; Liu X; Peng X; Gu J; Chen S; Zhang S
    FEBS Lett; 2014 Jun; 588(12):2095-100. PubMed ID: 24815695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of BPOZ2 Decreases Liver Fibrosis After Chronic Carbon Tetrachloride Administration in Mice.
    Zhang F; Dang S; Shu R; Xiang Y; Kuang Y; Fei J; Wang Z
    Int J Toxicol; 2015; 34(2):204-10. PubMed ID: 25568138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch.
    Xiang X; Lan H; Tang H; Yuan F; Xu Y; Zhao J; Li Y; Zhang W
    Diabetes; 2015 Feb; 64(2):519-28. PubMed ID: 25213336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.